A detailed history of Guyasuta Investment Advisors Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Guyasuta Investment Advisors Inc holds 30,597 shares of ABBV stock, worth $5.54 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
30,597
Previous 31,256 2.11%
Holding current value
$5.54 Million
Previous $5.36 Million 12.7%
% of portfolio
0.4%
Previous 0.37%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $107,970 - $131,358
-659 Reduced 2.11%
30,597 $6.04 Million
Q4 2023

Feb 05, 2024

SELL
$137.6 - $154.97 $172,688 - $194,487
-1,255 Reduced 3.86%
31,256 $4.84 Million
Q3 2023

Oct 25, 2023

BUY
$133.59 - $154.65 $103,398 - $119,699
774 Added 2.44%
32,511 $4.85 Million
Q2 2023

Jul 17, 2023

SELL
$132.51 - $164.9 $23,454 - $29,187
-177 Reduced 0.55%
31,737 $4.28 Million
Q1 2023

Apr 28, 2023

SELL
$144.61 - $166.54 $22,125 - $25,480
-153 Reduced 0.48%
31,914 $5.09 Million
Q4 2022

Jan 30, 2023

BUY
$138.31 - $165.87 $19,225 - $23,055
139 Added 0.44%
32,067 $5.19 Million
Q3 2022

Oct 25, 2022

BUY
$134.21 - $153.93 $12,078 - $13,853
90 Added 0.28%
31,928 $4.29 Million
Q2 2022

Jul 21, 2022

SELL
$137.62 - $174.96 $722,092 - $918,015
-5,247 Reduced 14.15%
31,838 $4.88 Million
Q1 2022

May 03, 2022

SELL
$131.98 - $163.75 $104,132 - $129,198
-789 Reduced 2.08%
37,085 $6.01 Million
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $203,436 - $230,931
1,912 Added 5.32%
37,874 $4.09 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $166,757 - $185,777
1,585 Added 4.61%
35,962 $4.05 Million
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $45,318 - $49,890
443 Added 1.31%
34,377 $3.72 Million
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $33,161 - $44,772
412 Added 1.23%
33,934 $3.64 Million
Q3 2020

Oct 28, 2020

BUY
$85.91 - $100.83 $256,441 - $300,977
2,985 Added 9.78%
33,522 $2.94 Million
Q2 2020

Aug 06, 2020

BUY
$73.37 - $98.18 $502,364 - $672,238
6,847 Added 28.9%
30,537 $3 Million
Q1 2020

Apr 28, 2020

BUY
$64.5 - $97.79 $100,362 - $152,161
1,556 Added 7.03%
23,690 $1.81 Million
Q4 2019

Feb 10, 2020

SELL
$72.13 - $90.25 $34,983 - $43,771
-485 Reduced 2.14%
22,134 $1.96 Million
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $74,969 - $92,457
-963 Reduced 4.08%
22,619 $2.09 Million
Q3 2018

Nov 08, 2018

SELL
$88.91 - $98.84 $46,677 - $51,891
-525 Reduced 2.18%
23,582 $2.23 Million
Q2 2018

Aug 07, 2018

BUY
$89.78 - $106.23 $57,548 - $68,093
641 Added 2.73%
24,107 $2.23 Million
Q1 2018

May 09, 2018

BUY
$92.01 - $123.21 $132,218 - $177,052
1,437 Added 6.52%
23,466 $2.22 Million
Q2 2017

Aug 09, 2017

BUY
N/A
22,029
22,029 $1.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Guyasuta Investment Advisors Inc Portfolio

Follow Guyasuta Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guyasuta Investment Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guyasuta Investment Advisors Inc with notifications on news.